查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197374

实验室冷冻机市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Laboratory Freezers Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，实验室冷冻机市场预计将以 4.5% 的复合年增长率增长。

由于实验室和诊所的迅速关闭，以及全球冷冻机销售和进口的下降，COVID-19 对实验室冷冻机市场产生了重大影响。 然而，随着 COVID-19 疫苗的推出和严格按照温度设置储存疫苗，对实验室冰柜和冰箱的需求增加了。 例如，根据 2022 年 10 月发布的“Moderna COVID-19”疫苗处理大纲，建议将疫苗保存在 -50度C 至 -15度C 的冰箱中直至到期。 此外，正如 2021 年 9 月发表的一篇论文所见，mRNA 平台使疫苗的快速开发成为可能，但由于需要超低温储存，其全球使用受到限制。 许多资源有限的国家缺乏冷链储存来进行大规模疫苗接种。 因此，这个市场在大流行期间产生了重大影响。 此外，在后大流行时代，随着限制的解除和 COVID-19 病例的减少，市场正在通过增加产品发布、实验室冷冻设置的进步以及针对不同疾病的疫苗生产的增加而实现增长。。

血液和血液成分需求增加、器官移植手术数量增加以及实验室冷冻机技术进步等因素正在推动预测期内的市场增长。 例如，根据 HRSA 2022 更新，美国将在 2021 年进行超过 40,000 例移植手术。 据同一消息来源称，全国移植等待名单上有 105,842 人，包括男性、女性和儿童。 此外，根据 NHF 2022 更新，每年约有 400 名男性婴儿出生时患有血友病 A，因此献血和输血浆的需求可能非常高，储存需求也很高。实验室级冰柜预计将用于 因此，随着血液相关问题的增加，对实验室冷冻机的需求将会增加，从而推动预测期内的市场增长。

在各种因素的推动下，实验室冷冻机行业在过去几十年取得了广泛的发展，包括製造商越来越重视开髮用于保存各种细胞的新产品。例如，2021 年 4 月，BioLife Solutions, Inc.，一家为细胞和基因治疗提供一流生物生产产品和服务组合的开发商和供应商，宣布推出新的高容量可控速率冷冻机 (HCRF) 生产线和最初出货给细胞治疗公司。 此外，在实验室冷冻机领域，产品发布、合作伙伴关係、併购预计将在预测期内推动市场增长。 例如，2022 年 1 月，Calibre Scientific 收购了总部位于英国牛津郡的实验室耗材和设备分销商 Medline Scientific。 Medline Scientific 进一步加强了 Calibre Scientific 在英国不断增长的销售业务。

由于对血液和血液成分的需求增加、实验室冷冻产品的推出增加、实验室冷冻技术的进步以及器官移植程序的增加，实验室冷冻市场将在预测期内增长。预计将显示 然而，实验室冷冻机的高成本预计将在预测期内抑制全球市场的增长。

实验室冷冻机市场趋势

等离子冰箱领域预计在预测期内增长

血浆冷冻机使用-30 或-40 安全储存血库、实验室、药房和医院血浆冷冻机中的新鲜冷冻血浆、红细胞、浓缩血小板、疫苗和测试样品。它提供并保持 度 的製冷温度C。 由于单采术治疗的增加和对新鲜冷冻血浆储存 (FFP) 的需求增加，血浆冷冻机部分可能会出现显着增长。 根据美国单采术协会 (ASFA)，血浆单采术是美国最常见的单采术。

此外，在预测期内，血浆冷冻领域的竞争对手、产品发布和合作预计将推动市场增长。 例如，2021 年 3 月，Helmer Scientific 推出了用于疫苗、药物、血液疗法和样本储存的 GX Solutions Laboratory 和 Plasma Freezers。 采用 OptiCool 技术的 GX Solutions 医用级冷冻机专为关键医疗保健应用而设计，通过热性能、降噪、减少能源使用和低全球变暖潜能值 (GWP) 来支持环境可持续性（比例因子）技术。

此外，在预测期内，政府对等离子存储厂发展的举措和资金预计将推动市场增长。 例如，2022 年 4 月，Terumo Blood and Cell Technologies 从美国政府获得了 1060 万美元的合同，继续开发冻干血浆。 该协议承认，医疗技术公司联盟 MTEC 和 501(c)(3) 生物医学技术联盟已根据其他商业协议 (OTA) 与美国陆军医学研究与开发司令部合作，为战场提供医疗保健。它由国防与健康管理局 (DHA) 赞助，由海军医学研究中心 (NMRC) 运营，旨在推动 因此，作为冷冻干燥等离子优势发展的一部分，预计对等离子干燥机的需求将增加，从而推动预测期内的市场增长。

此外，献血和输血的增加预计将推动市场增长，因为血液中的血浆必须在献血后 24 小时内冷冻以保存宝贵的凝血因子。例如，根据新加坡政府2022年5月的报告，42.6%的人捐了O+ve血，25.4%的人捐了B+ve血。 到 2022 年，新加坡每小时需要 14 个单位的血液。 这相当于每天 325 个学分，每年 118,750 个学分。

因此，由于献血和输血的增加、政府的举措以及对血浆储存厂发展的资助，预计血浆冷冻器部分在预测期内将出现增长。

预计在预测期内，北美的实验室冷冻机市场将出现增长。

由于该地区领先公司的存在、器官移植的增加以及实验室冷冻机的技术进步，预计北美实验室冷冻机市场将显着增长。 例如，根据CDC 2022更新，在美国，移植最多的器官是肾臟、肝臟、心臟、肺、胰腺和肠道。 此外，预计该地区献血量的增加将推动预测期内的市场增长。 例如，根据美国红十字会 2022 年的更新，在美国每两秒钟就有一个人需要血液和/或血小板。 因此，随着献血人数的增加，对实验室冷冻柜的需求也随之增加，因为采集的血液被储存在冷库中，以保护输血的血液成分。

此外，研究区域免疫接种的增加也有望在预测期内推动市场增长。 例如，根据 WHO 2022 更新，截至 2022 年 11 月，美国已收到 633,076,067 剂 COVID-19 疫苗。 随着疫苗接种的增加，对实验室冷冻柜的需求也在增加，因为建议将疫苗储存在标准温度下的冷藏库或冷冻柜中，以保持疫苗的活力。 因此，研究区的市场预计会随着冷冻柜需求的增加而增长。 此外，研究区域与实验室冷冻机相关的主要参与者的存在、收购、合併和联盟预计将在预测期内推动市场增长。 例如，2021 年 10 月，创新测试和工艺解决方案供应商新泽西州 inTEST 公司将收购医疗冷链市场冷冻保存解决方案开发商 Z-Sciences Corp. 的大部分资产。一切都在

由于疫苗接种增加和献血增加，在预测期内，北美地区的实验室冷冻机市场可能会增长。

实验室冷冻机市场竞争对手分析

这个市场的竞争很低。 实验室冷冻机市场的主要参与者包括 Arctiko A/S、Antylia Scientific、LabRepCo Holding Corporation、Eppendorf AG、Evermed S.R.L.、Haier lnc.、Helmer Scientific、Panasonic Healthcare、Philipp Kirsch GmbH 和 Thermo Fisher Scientific, Inc。产品供应世界各地。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 对血液和血液成分的需求增加
    • 增加器官移植手术的数量
    • 实验室冷冻机的技术进步
  • 市场製约因素
    • 实验室冰箱成本高
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按类型
    • 等离子冰箱
    • □冰箱
    • 可燃冷冻机
    • 其他
  • 最终用户
    • 血库
    • 医学实验室
    • 製药公司、生物技术公司
    • 其他
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Arctiko A/S
    • Antylia Scientific
    • LabRepCo Holding Corporation
    • Eppendorf AG
    • Evermed S.R.L.
    • Haier lnc.
    • Helmer Scientific
    • Panasonic Healthcare Co., Ltd.
    • Philipp Kirsch GmbH
    • Thermo Fisher Scientific, Inc.

第7章 市场机会与今后动向

简介目录
Product Code: 67570

The laboratory freezers market is poised to grow at a CAGR of 4.5% over the forecast period.

COVID-19 had a significant impact on the laboratory freezers market owing to the factors such as the rapid shut of laboratories and clinics led to decreased sales as well as the import of freezers worldwide. Even though, as the vaccine for COVID-19 had been introduced, the demand for laboratory freezers and refrigerators increased as vaccine storage strictly followed the temperature settings. For instance, as per the Moderna COVID-19 vaccine handling summary published in October 2022, vaccines are advised to be stored in freezers between -50°C and -15°C (-58°F and 5°F) until the expiration date. Furthermore, as per the article published in September 2021, the mRNA platform allowed for the rapid development of vaccines, but their global use was limited by the need for ultracold storage. Most resource-constrained countries lack cold chain storage to carry out mass vaccinations. Hence, the studied market witnessed a significant impact throughout the pandemic phase. Furthermore, in the post-pandemic era, as the restrictions were lifted and COVID-19 cases were reduced, the market is witnessing growth through the rise in product launches, advancements in laboratory freezer settings, and an increase in vaccine production for different diseases.

Factors such as increasing demand for blood and blood components, the growing number of organ transplant procedures, and technological advancements in laboratory freezers drive market growth over the forecast period. For instance, as per the HRSA 2022 update, in the United States, more than 40,000 transplants were performed in 2021. As per the same source, there are 105,842 people including men, women, and children on the national transplant waiting list. Furthermore, as per the 2022 update from NHF, every year, 400 or so male babies are born with hemophilia A. Hence, there is likely to be a huge need for blood donation and plasma transfusions, which is anticipated to utilize cold storage or laboratory-grade freezers for preservation. Hence, as the number of blood-related issues increases, the laboratory freezer demand rises thereby boosting the market growth over the forecast period.

The laboratory freezers industry has observed extensive developments in the last few decades supported by various factors such as a rise in the focus of manufacturers on developing novel products for preserving different cells. For instance, in April 2021, BioLife Solutions, Inc., a developer, and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, launched a new line of high-capacity controlled rate freezers (HCRF), with an initial shipment to a cell therapy company. Furthermore, product launches, collaborations, mergers, and acquisitions in the field of laboratory freezers are anticipated to boost market growth over the forecast period. For instance, in January 2022, Calibre Scientific acquired Medline Scientific, a distributor of laboratory consumables and equipment with headquarters in Oxfordshire, United Kingdom. Medline Scientific further enhances Calibre Scientific's growing distribution presence in the United Kingdom.

Therefore, due to the increasing demand for blood and blood components, the rise in laboratory freezer product launches, technological advancements in a laboratory freezers, and a growing number of organ transplant procedures, the laboratory freezers market is anticipated to witness growth over the forecast period. However, the high cost of laboratory freezers is expected to restrain the growth of the global market over the forecast period.

Laboratory Freezers Market Trends

Plasma Freezers Segment is Expected to Witness a Growth Over the Forecast Period

Plasma freezers provide and maintain the freezing temperature at -30 or -40 °C for safe storage of fresh frozen plasma, red cells, and platelet concentrates whole blood, vaccines, and test samples in blood banks, research institutes, pharmacies, and hospital plasma freezers. The plasma freezers segment is likely to witness significant growth owing to an increase in the number of apheresis treatments and an increase in demand for fresh frozen plasma storage (FFP). Plasma exchange is the most prevalent apheresis technique in the United States, according to the American Society for Apheresis (ASFA).

Furthermore, the presence of competitors, product launches, and collaborations in the field of plasma freezers are likely to boost the market growth over the forecast period. For instance, in March 2021, Helmer Scientific launched GX Solutions Laboratory and Plasma Freezers for vaccines, medications, blood therapies, and sample storage. Powered by OptiCool technology GX Solutions medical-grade freezers are designed for important healthcare applications through temperature performance, noise reduction, and reduced energy use, while also using low Global Warming Potential (GWP) technology to assist environmental sustainability.

Moreover, government initiatives and funding for the development of plasma storage plants are anticipated to boost market growth over the forecast period. For instance, in April 2022, Terumo Blood and Cell Technologies received USD 10.6M contract From U.S. Government to continue freeze-dried plasma development. The contract is with MTEC, the Medical Technology Enterprise Consortium, a 501(c)(3) biomedical technology consortium collaborating under an Other Transaction Agreement (OTA) with the U.S. Army Medical Research and Development Command and is sponsored by the Defense Health Agency (DHA) and managed by the Naval Medical Research Center (NMRC) to drive healthcare advances for the battlefield. Hence, as a part of the development owing to the advantages of freeze-dried plasma, the demand for plasma dryers is likely to increase, thereby driving market growth over the forecast period.

Additionally, the increase in blood donation and transfusions are anticipated to boost the market growth since the plasma from the blood needs to be frozen within 24 hours of being donated to preserve the valuable clotting factors. For instance, as per the May 2022 report from the Government of Singapore, 42.6% of people donated O+ve blood and 25.4% donated B+ve blood. In 2022, 14 units of blood are required every hour in Singapore. That is 325 units every day or 118,750 units in the year.

Hence, due to the rise in blood donations and transfusions, and the increase in government initiatives and funding for the development of plasma storage plants, the plasma freezers segment is anticipated to witness growth over the forecast period.

North America is Expected to Witness a Growth in the Laboratory Freezers Market Over the Forecast Period

The laboratory freezers market in the North American region is anticipated to grow significantly as a result of the presence of prominent players in the region, the growing number of organ transplant procedures, and technological advancements in laboratory freezers. For instance, according to the CDC 2022 update, in the United States, the most transplanted organs are the kidney, liver, heart, lungs, pancreas, and intestines. Furthermore, a rise in blood donation in the region is anticipated to boost the market growth over the forecast period. For instance, as per the 2022 update from American Red Cross, every 2 seconds someone in the U.S. needs blood and or platelets. Approximately 29,000 units of red blood cells are needed every day in the U. S. Hence, as the number of blood donations increases, the demand for laboratory freezers also rises as the collected blood is stored in cold storage to protect the blood components for transfusion.

Furthermore, the rise in vaccinations and immunization programs in the studied region is likely to boost market growth over the forecast period. For instance, as per the WHO 2022 update, 633,076,067 COVID-19 vaccine doses had been administered in the United States as of November 2022. As a result of the increase in vaccinations, there is a strong need for laboratory freezers, as vaccines are advised to keep in cold storage or a freezer under a standard temperature to keep them viable. As a result, as the demand for freezers increases, the market is likely to grow in the studied region. Moreover, the presence of key players, acquisitions, mergers, and collaborations related to the laboratory freezers in the studied region is anticipated to boost market growth over the forecast period. For instance, in October 2021, New Jersey-based inTEST Corporation, a supplier of innovative test and process solutions acquired substantially all of the assets of Z-Sciences Corp., a developer of ultra-cold storage solutions for the medical cold chain market.

Hence, due to the rise in vaccinations and immunization programs and the rise in blood donation, the laboratory freezers market is likely to witness growth in the North America region over the forecast period.

Laboratory Freezers Market Competitor Analysis

The market studied is moderately competitive. Some of the major players in the laboratory freezers market include Arctiko A/S, Antylia Scientific, LabRepCo Holding Corporation, Eppendorf AG, Evermed S.R.L., Haier lnc., Helmer Scientific, Panasonic Healthcare Co., Ltd., Philipp Kirsch GmbH, and Thermo Fisher Scientific, Inc. which provides these products across the globe.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand for Blood and Blood Components
    • 4.2.2 Growing Number of Organ Transplant Procedures
    • 4.2.3 Technological Advancements in Laboratory Freezers
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Laboratory Freezers
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Plasma Freezers
    • 5.1.2 Enzyme Freezers
    • 5.1.3 Flammable Material Freezers
    • 5.1.4 Others
  • 5.2 By End User
    • 5.2.1 Blood Banks
    • 5.2.2 Medical Laboratories
    • 5.2.3 Pharmaceutical & Biotechnology Companies
    • 5.2.4 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Arctiko A/S
    • 6.1.2 Antylia Scientific
    • 6.1.3 LabRepCo Holding Corporation
    • 6.1.4 Eppendorf AG
    • 6.1.5 Evermed S.R.L.
    • 6.1.6 Haier lnc.
    • 6.1.7 Helmer Scientific
    • 6.1.8 Panasonic Healthcare Co., Ltd.
    • 6.1.9 Philipp Kirsch GmbH
    • 6.1.10 Thermo Fisher Scientific, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS